FOXO TECHNOLOGIES INC., CONFIRMS DETAILS OF SPECIAL MEETING OF SHAREHOLDERS ON JANUARY 17, 2025.
FOXO Technologies Inc. (NYSE American: FOXO) has announced its Special Meeting of Shareholders scheduled for January 17, 2025, at 10:30 am EST. The virtual meeting follows the Company's Definitive Proxy Statement filed with the SEC on January 6, 2025. Shareholders of record as of January 3, 2025, will be eligible to vote on the proposed approvals.
Shareholders can vote either online at www.cstproxyvote.com or by attending the virtual meeting at https://www.cstproxy.com/foxotechnologies/2025 using their 12-digit control number. The Board of Directors recommends voting in favor of the Proposals listed on the Proxy Card. CEO Seamus Lagan expressed that the meeting will fulfill obligations from recent acquisition agreements and highlighted the company's transformation in the second half of 2024 as a foundation for building significant shareholder value.
FOXO Technologies Inc. (NYSE American: FOXO) ha annunciato la sua Assemblea Annuale degli Azionisti programmata per il 17 gennaio 2025, alle 10:30 ora EST. La riunione virtuale segue la Dichiarazione Definitiva di Rappresentanza depositata presso la SEC il 6 gennaio 2025. Gli azionisti registrati entro il 3 gennaio 2025, potranno votare per le approvazioni proposte.
Gli azionisti possono votare online su www.cstproxyvote.com o partecipando alla riunione virtuale su https://www.cstproxy.com/foxotechnologies/2025 utilizzando il proprio numero di controllo a 12 cifre. Il Consiglio di Amministrazione raccomanda di votare a favore delle Proposte indicate sulla Scheda di Rappresentanza. Il CEO Seamus Lagan ha dichiarato che l'incontro soddisferà gli obblighi derivanti dagli accordi di acquisizione recenti e ha sottolineato la trasformazione dell'azienda nella seconda metà del 2024 come base per costruire un significativo valore per gli azionisti.
FOXO Technologies Inc. (NYSE American: FOXO) ha anunciado su Junta Especial de Accionistas programada para el 17 de enero de 2025, a las 10:30 am EST. La reunión virtual sigue la Declaración Definitiva de Poderes presentada ante la SEC el 6 de enero de 2025. Los accionistas registrados hasta el 3 de enero de 2025, serán elegibles para votar sobre las aprobaciones propuestas.
Los accionistas pueden votar en línea en www.cstproxyvote.com o asistiendo a la reunión virtual en https://www.cstproxy.com/foxotechnologies/2025 utilizando su número de control de 12 dígitos. La Junta de Directores recomienda votar a favor de las Propuestas enumeradas en la Tarjeta de Poderes. El CEO Seamus Lagan expresó que la reunión cumplirá con las obligaciones de recientes acuerdos de adquisición y destacó la transformación de la empresa en la segunda mitad de 2024 como base para construir un valor significativo para los accionistas.
FOXO Technologies Inc. (NYSE American: FOXO)는 2025년 1월 17일 오전 10시 30분 EST로 예정된 주주 특별 회의를 발표했습니다. 가상 회의는 2025년 1월 6일 SEC에 제출된 회사의 최종 대리인 성명서에 따라 진행됩니다. 2025년 1월 3일 기준으로 등록된 주주는 제안된 승인 사항에 대해 투표할 수 있습니다.
주주는 www.cstproxyvote.com에서 온라인으로 투표하거나 https://www.cstproxy.com/foxotechnologies/2025에서 12자리 제어 번호를 사용하여 가상 회의에 참석하여 투표할 수 있습니다. 이사회는 위임장에 나열된 제안에 찬성 투표를 권장합니다. CEO Seamus Lagan은 이번 회의가 최근 인수 계약에서의 의무를 이행할 것이라고 밝히며, 2024년 하반기의 회사 변화가 주주 가치를 구축하는 기초가 될 것이라고 강조했습니다.
FOXO Technologies Inc. (NYSE American: FOXO) a annoncé sa Réunion Spéciale des Actionnaires prévue pour le 17 janvier 2025 à 10h30 EST. La réunion virtuelle fait suite à la Déclaration de Procuration Définitive déposée auprès de la SEC le 6 janvier 2025. Les actionnaires enregistrés au 3 janvier 2025 seront éligibles pour voter sur les approbations proposées.
Les actionnaires peuvent voter soit en ligne sur www.cstproxyvote.com, soit en assistant à la réunion virtuelle à l'adresse https://www.cstproxy.com/foxotechnologies/2025 en utilisant leur numéro de contrôle à 12 chiffres. Le Conseil d'Administration recommande de voter en faveur des propositions énoncées sur la Carte de Procuration. Le CEO Seamus Lagan a exprimé que la réunion répondra aux obligations découlant des récents accords d'acquisition et a souligné la transformation de l'entreprise dans la seconde moitié de 2024 comme base pour créer une valeur significative pour les actionnaires.
FOXO Technologies Inc. (NYSE American: FOXO) hat die Einberufung seiner Sonderversammlung der Aktionäre für den 17. Januar 2025 um 10:30 Uhr EST bekannt gegeben. Das virtuelle Treffen erfolgt nach der am 6. Januar 2025 bei der SEC eingereichten endgültigen Vollmachtserklärung des Unternehmens. Aktionäre, die am 3. Januar 2025 im Aktienregister stehen, sind berechtigt, über die vorgeschlagenen Genehmigungen abzustimmen.
Aktionäre können entweder online unter www.cstproxyvote.com abstimmen oder an der virtuellen Sitzung unter https://www.cstproxy.com/foxotechnologies/2025 teilnehmen, indem sie ihre 12-stellige Kontrollnummer verwenden. Der Vorstand empfiehlt, den auf der Vollmacht angegebenen Vorschlägen zuzustimmen. CEO Seamus Lagan erklärte, dass die Sitzung den Verpflichtungen aus den jüngsten Übernahmevereinbarungen nachkommen wird und hob die Transformation des Unternehmens in der zweiten Hälfte von 2024 als Grundlage zur Schaffung eines erheblichen Aktionärswerts hervor.
- Company completed recent acquisitions indicating business expansion
- Management reports successful transformation in second half of 2024
- None.
MINNEAPOLIS, MN, Jan. 16, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), will hold its previously announced Special Meeting of its Shareholders at 10:30 am EST on Friday, January 17, 2025.
Following the filing of its Definitive Proxy Statement filed with the SEC on January 6, 2025, the Company is holding a virtual meeting of its shareholders (the “Special Meeting”) on Friday, January 17, 2025, at 10:30 a.m. Eastern Standard Time.
Shareholders of record on January 3, 2025, will be entitled to vote on the approvals requested. All shareholder votes are important. There are two ways for our shareholders to vote.
Shareholders can use the internet. Please go to www.cstproxyvote.com. Have your proxy card to hand and when you access the website, please follow the prompts to cast your votes.
Or, should a shareholder wish to attend the meeting, please login to https://www.cstproxy.com/foxotechnologies/2025 when the meeting commences at 10:30 a.m. EST on Friday January 17, 2025. You will need your 12-digit control number (that is printed on your Proxy Card). During the meeting you will be able to submit your vote electronically.
The Board of Directors asks that all shareholders vote in favor of the Proposals listed on the Proxy Card and appreciates continued support from its shareholders.
“We look forward to the continued support of our shareholders for this Special Meeting taking place tomorrow,” said Seamus Lagan, CEO of FOXO. “This meeting will complete the obligations from the acquisition agreements that the Company has completed in recent months. We look forward to a successful outcome to the meeting and believe the transformation of FOXO in the second half of 2024 creates a new foundation on which we can built a significant and valuable company for the benefit of our shareholders.”
About FOXO Technologies Inc. (“FOXO”)
FOXO owns and operates three subsidiaries.
Foxo Labs, Inc. is a biotechnology company dedicated to improving human health and life span through the development of cutting-edge technology and product solutions for various industries.
Myrtle Recovery Centers, Inc., a 30-bed behavioral health facility in East Tennessee. Myrtle provides inpatient services for detox and residential treatment and outpatient services for MAT and OBOT Programs.
Rennova Community Health, Inc., owns and operates Scott County Community Hospital, Inc. (d/b/a Big South Fork Medical), a critical access designated (CAH) hospital in East Tennessee.
For more information about FOXO, visit www.foxotechnologies.com.
Forward-Looking Statements
This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the FOXO’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. These factors include, but are not limited to the risk of changes in the competitive and highly regulated industries in which FOXO operates; variations in operating performance across competitors or changes in laws and regulations affecting FOXO’s business; the ability to implement FOXO’s business plans, forecasts, and other expectations; the ability to obtain financing; the risk that FOXO has a history of losses and may not achieve or maintain profitability in the future; potential inability of FOXO to establish or maintain relationships required to advance its goals or to achieve its commercialization and development plans; the enforceability of FOXO’s intellectual property, including its patents and the potential infringement on the intellectual property rights of others; and the risk of downturns and a changing regulatory landscape in the highly competitive biotechnology industry or in the markets or industries in which FOXO operates. The foregoing list of factors is not exhaustive. Readers should carefully consider the foregoing factors and the other risks and uncertainties discussed in FOXO’s most recent reports on Forms 10-K and 10-Q, particularly the “Risk Factors” sections of those reports, and in other documents FOXO has filed, or will file, with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and FOXO assumes no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
Contact:
Sebastien Sainsbury
ssainsbury@foxotechnologies.com
(561) 485-0151
FAQ
When is FOXO Technologies (FOXO) holding its Special Meeting of Shareholders?
How can shareholders vote at FOXO's January 2025 Special Meeting?
What is the record date for FOXO's January 2025 Special Meeting?
What is the purpose of FOXO's January 2025 Special Meeting?
